ArticleBritish journal of clinical pharmacology2022

Pharmacokinetically-guided dosing to improve the efficacy of brigatinib in non-small cell lung cancer patients.

Simon E Koele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.